sgCtr- LentiCRISPRv2 Citations (6)
Originally described in: Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.Gao W, Li W, Xiao T, Liu XS, Kaelin WG Jr Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1027-1032. doi: 10.1073/pnas.1619726114. Epub 2017 Jan 12. PubMed Journal
Articles Citing sgCtr- LentiCRISPRv2
Articles |
---|
IRE1alpha Promotes Zika Virus Infection via XBP1. Kolpikova EP, Tronco AR, Hartigh ABD, Jackson KJ, Iwawaki T, Fink SL. Viruses. 2020 Mar 3;12(3). pii: v12030278. doi: 10.3390/v12030278. PubMed |
Creb5 establishes the competence for Prg4 expression in articular cartilage. Zhang CH, Gao Y, Jadhav U, Hung HH, Holton KM, Grodzinsky AJ, Shivdasani RA, Lassar AB. Commun Biol. 2021 Mar 12;4(1):332. doi: 10.1038/s42003-021-01857-0. PubMed |
Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation. Zhou X, Li JW, Chen Z, Ni W, Li X, Yang R, Shen H, Liu J, DeMayo FJ, Lu J, Kaye FJ, Wu L. Elife. 2021 Jun 18;10. pii: 66095. doi: 10.7554/eLife.66095. PubMed |
A genome-wide CRISPR-Cas9 knockout screen identifies essential and growth-restricting genes in human trophoblast stem cells. Dong C, Fu S, Karvas RM, Chew B, Fischer LA, Xing X, Harrison JK, Popli P, Kommagani R, Wang T, Zhang B, Theunissen TW. Nat Commun. 2022 May 10;13(1):2548. doi: 10.1038/s41467-022-30207-9. PubMed |
FSCN1 as a new druggable target in adrenocortical carcinoma. Ruggiero C, Tamburello M, Rossini E, Zini S, Durand N, Cantini G, Cioppi F, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Landwehr LS, Weigand I, Kurlbaum M, Zizioli D, Turtoi A, Yang S, Berruti A, Luconi M, Sigala S, Lalli E. Int J Cancer. 2023 Jul 1;153(1):210-223. doi: 10.1002/ijc.34526. Epub 2023 Mar 31. PubMed |
SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity. Kang JA, Kim YJ, Jang KY, Moon HW, Lee H, Lee S, Song HK, Cho SW, Yoo YS, Han HG, Kim MJ, Chung MJ, Choi CY, Lee C, Chung C, Hur GM, Kim YS, Jeon YJ. Exp Mol Med. 2024 Mar;56(3):656-673. doi: 10.1038/s12276-024-01194-2. Epub 2024 Mar 5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.